Sight Sciences (NASDAQ: SGHT) insider plans sale of 6,308 shares of stock

Rhea-AI Filing Summary

Sight Sciences insider transaction: A notice has been filed to sell 6,308 shares of common stock of Sight Sciences through Fidelity Brokerage Services LLC on or about 01/16/2026, with the shares listed on NASDAQ. The shares relate to restricted stock that vested on 01/15/2026, acquired from the issuer as compensation.

As context, the notice reports 52,871,731 shares of common stock outstanding. It also lists prior sales during the past three months by Jeremy Hayden, including 3,150 shares sold on 11/12/2025 for gross proceeds of 25,227.78, 44,850 shares sold on 11/25/2025 for 362,596.77, 9,385 shares sold on 01/05/2026 for 73,418.85, and 1,785 shares sold on 01/06/2026 for 13,354.66.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6308	41741.93	52871731	01/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Restricted Stock Vesting	Issuer			6308	01/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jeremy Hayden 4040 Campbell Ave, Suite 100 Menlo Park CA 94025	Common	11/12/2025	3150	25227.78
Jeremy Hayden 4040 Campbell Ave, Suite 100 Menlo Park CA 94025	Common	11/25/2025	44850	362596.77
Jeremy Hayden 4040 Campbell Ave, Suite 100 Menlo Park CA 94025	Common	01/05/2026	9385	73418.85
Jeremy Hayden 4040 Campbell Ave, Suite 100 Menlo Park CA 94025	Common	01/06/2026	1785	13354.66

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transaction is disclosed for SGHT in this Form 144?

The notice discloses a proposed sale of 6,308 shares of Sight Sciences common stock through Fidelity Brokerage Services LLC, with an approximate sale date of 01/16/2026 on NASDAQ.

How were the SGHT shares being sold acquired by the insider?

The 6,308 shares of Sight Sciences common stock were acquired on 01/15/2026 through restricted stock vesting from the issuer as compensation.

How many Sight Sciences shares are reported as outstanding?

The notice reports that 52,871,731 shares of Sight Sciences common stock were outstanding in connection with this proposed sale.

What prior SGHT share sales by the same person are disclosed?

The filing lists prior three-month sales by Jeremy Hayden: 3,150 shares on 11/12/2025 for 25,227.78, 44,850 shares on 11/25/2025 for 362,596.77, 9,385 shares on 01/05/2026 for 73,418.85, and 1,785 shares on 01/06/2026 for 13,354.66 in gross proceeds.

Which broker is handling the proposed SGHT share sale?

The proposed sale of 6,308 Sight Sciences common shares is to be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

What representation does the selling person make in this SGHT Form 144?

By signing the notice, the selling person represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, and that any Rule 10b5-1 trading plan or instructions reflect that representation as of their adoption date.